SavedAdd your journal

Journals / Türk Osteoporoz Dergisi / 2016 / Cilt: 22 - Sayı: 1

Heparin Induced Osteoporosis Following Pregnancy

Heparin Kullanımına Bağlı Gelişen Gebelik Sonrası Osteoporozu

İlknur AKTAŞ
Pınar AKPINAR
Arzu ATICI
Duygu Geler KÜLCÜ
Feyza Ünlü ÖZKAN
Fatma Nur BOY SOYLU
Pages
54–57
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was aimed to present a case with low molecular weight heparin induced osteoporosis during the lactation period and to emphasize the risk factors of osteoporosis during pregnancy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Although pregnancy and lactation are physiological events, patients who have risk factors can develop osteoporosis.
📊
Key Findings & Data:Heparin which affects bone metabolism induces osteoporosis and osteoporosis may be hidden under the shadow of primary illness.
💡
Conclusion & Impact:It was aimed to present a case with low molecular weight heparin induced osteoporosis during the lactation period and to emphasize the risk factors of osteoporosis during pregnancy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Although pregnancy and lactation are physiological events, patients who have risk factors can develop osteoporosis. Heparin which affects bone metabolism induces osteoporosis and osteoporosis may be hidden under the shadow of primary illness. It was aimed to present a case with low molecular weight heparin induced osteoporosis during the lactation period and to emphasize the risk factors of osteoporosis during pregnancy

Özet

Gebelik ve emzirme fizyolojik olaylar olsa da risk faktörleri olan hastalarda osteoporoz gelişebilmektedir. Kemik metabolizmasını etkileyen ilaçlardan olan heparin osteoporoza yol açmakta ve osteoporoz birincil hastalığın gölgesinde fark edilemeyebilmektedir. Yazımızda, gebelik döneminde düşük molekül ağırlıklı heparin kullanımı öyküsü olup laktasyon döneminde osteoporoz saptadığımız hastamızı sunarak, gebelik döneminde osteoporoz risk faktörlerinin sorgulanıp gerekli önlemlerin alınmasının gerekliliğini vurgulamayı amaçladık.

🔖

Cite This Article

AKTAŞ, İ., AKPINAR, P., ATICI, A., KÜLCÜ, D. G., ÖZKAN, F. Ü., SOYLU, F. N. B. (2022). Heparin Induced Osteoporosis Following Pregnancy. Türk Osteoporoz Dergisi, Cilt: 22 - Sayı: 1, 54–57. https://ajindex.com/articles/639734

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Eryavuz-Sarıdoğan M. Osteoporozun tanımı ve sınıflandırılması. İçinde: Gökçe-Kutsal Y. editör. Osteoporoz. 2nd ed. Ankara: Güneş Tıp Kitabevleri; 2005. p. 1-4.
  2. Gökkaya NKO, Gökçe-Kutsal Y. İlaca bağlı osteoporoz. Turk J Osteoporos 2011;17:30-6.
  3. Griffith GC, Nichols G Jr, Asher JD, Flanagan B. Heparin osteoporosis. JAMA 1965;193:91-4.
  4. Lowe H, Shane E. Osteoporosis associated with illnesses and medications. In: Marcus R, Feldman D, Nelson DA, Rosen CJ, editors. Osteoporosis 3rd ed. San Diego, California: Elsevier Academic Pres; 2008.p.1283-1314.
  5. Nordin BE, Roper A. Post-pregnancy osteoporosis; A syndrome? Lancet 1955;1:431-4.
  6. Akyüz G, Bayındır Ö. Gebelik ile ilişkili osteoporoz. Türk Fiz Tıp Rehab Derg 2013; 59:145-50.
  7. Khalifa P, Marie-Scemama L. Long-term low-molecular-weight heparin therapy during pregnancy: Is there a bone risk? Therapie 2013;68:37-42.
  8. Rajgopal R, Butcher M, Weitz JI, Shaughnessy SG. Heparin synergistically enhances interleukin-11 signaling through up-regulation of the MAPK pathway. J Biol Chem 2006;281:20780- 7. Panday K, Gona A, Humphrey MB. Medication-induced osteoporosis: Screening and treatment strategies. Ther Adv Musculoskel Dis 2014;6:185-202.
  9. Wisser J, Florio I, Neff M, König V, Huch R, Huch A, et al. Changes in bone density and metabolism in pregnancy. Acta Obstet Gynecol Scand 2005;84:349-54.
  10. O'Brien KO, Nathanson MS, Mancini J, Witter FR. Calcium absorption is significantly higher in adolescents during pregnancy than in the early postpartum period. Am J Clin Nutr 2003;78:1188- 93. Yano K, Shibata O, Mizuno A, Kobayashi F, Higashio K, Morinaga T, et al. Immunological study on circulating murine osteoprotegerin/osteoclastogenesis inhibitory factor (OPG/OCIF): Possible role of OPG/OCIF in the prevention of osteoporosis in pregnancy. Biochem Biophys Res Commun 2001;288:217-24.
  11. Ofluoglu O, Ofluoglu D. A case report: Pregnancy-induced severe osteoporosis with eight vertebral fractures. Rheumatol Int 2008;29:197-201.